主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
WGS
#1574
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.35%
每月变动
-16.98%
6个月变化
-37.42%
年变化
-21.08%
前一天收盘价
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
交易量
69
市场
股票
医疗保健
WGS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG因增长预期后置下调GeneDx目标价
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx 2025年第四季度业绩:营收增长54%,2026年激进扩张计划
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
Canaccord Genuity重申GeneDx股票买入评级,维持170美元目标价
TD Cowen在业绩电话会议前维持GeneDx股票买入评级
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target